
i
Credit: National Institute of Allergy and Infectious Diseases-Rocky Mountain Laboratories, NIH
In response to the unprecedented threat caused by the COVID-19 outbreak, IDDO is working with key stakeholders to identify how our expertise can be used optimally. Our technical and personnel resources are mobilised to address the knowledge gaps and improve outcomes for people affected by the novel coronavirus.
Explore COVID-19 clinical trials around the world in an open-access, cloud-based knowledge graph. The visualisation is based on IDDO’s living systematic review.
Explore our COVID-19 publications
Medicine Quality and COVID-19
IDDO’s Medicine Quality Research Group has developed a system for collating and curating global data on the quality of essential medical products and occurrence of substandard and falsified (SF) medical products in the lay press – the MQM Globe.
News